Ferrière, J-M <br/><br/>
[The advantages of antiangiogenics in neoadjuvant and adjuvant locally advanced and metastatic kidney cancer: two case studies].  [electronic resource] 

 -  Progres en urologie : journal de l'Association francaise d'urologie et de la Societe francaise d'urologie  Jul 2008 
 - S88-91 p.  digital 
<br/><br/> Publication Type: Case Reports; English Abstract; Journal Article 
<br/><br/><label>ISSN: </label>1166-7087 
<br/><br/><label>Standard No.: </label>10.1016/S1166-7087(08)73668-6  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Angiogenesis Inhibitors--therapeutic use<br/>Carcinoma, Renal Cell--drug therapy<br/>Humans<br/>Kidney Neoplasms--drug therapy<br/>Male<br/>Middle Aged<br/>Neoadjuvant Therapy<br/>Neoplasm Staging